{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T22:42:16Z","timestamp":1785796936085,"version":"3.56.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:00:00Z","timestamp":1756425600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014653","name":"NIHR Manchester Biomedical Research Centre","doi-asserted-by":"publisher","award":["NIHR203308"],"award-info":[{"award-number":["NIHR203308"]}],"id":[{"id":"10.13039\/100014653","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013342","name":"NIHR Imperial Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013342","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002909","name":"Comisi\u00f3n Nacional de Energ\u00eda At\u00f3mica, Gobierno de Argentina","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002909","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ctro.2025.101040","type":"journal-article","created":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T06:13:52Z","timestamp":1756707232000},"page":"101040","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Continuous \u03b2\u2212 particle exposure: A study of DNA damage in ex vivo peripheral blood mononuclear cells irradiation with Radioiodine"],"prefix":"10.1016","volume":"55","author":[{"given":"Laura","family":"Mazzitelli-Fuentes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8478-2200","authenticated-orcid":false,"given":"Lara","family":"Negrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Venier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Humberto","family":"Romano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jer\u00f3nimo","family":"Leberle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1575-1179","authenticated-orcid":false,"given":"Maria Soledad","family":"Ausas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ananya","family":"Choudhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3928-339X","authenticated-orcid":false,"given":"Luisa V.","family":"Biolatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.ctro.2025.101040_b0005","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41573-020-0073-9","article-title":"Radiopharmaceutical therapy in cancer: clinical advances and challenges","volume":"19","author":"Sgouros","year":"2020","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.ctro.2025.101040_b0010","doi-asserted-by":"crossref","DOI":"10.3389\/fnume.2023.1209823","article-title":"Can it find its way to the nuclear medicine clinic?","volume":"3","author":"Bolcaen","year":"2023","journal-title":"Front Nucl Med"},{"issue":"8","key":"10.1016\/j.ctro.2025.101040_b0015","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/s41571-022-00652-y","article-title":"Radiotheranostics in oncology: current challenges and emerging opportunities","volume":"19","author":"Bodei","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2025.101040_b0020","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s40658-020-00339-2","article-title":"Kidney dosimetry in 777 patients during 177Lu-DOTATATE therapy: aspects on extrapolations and measurement time points","volume":"7","author":"Sandstr\u00f6m","year":"2020","journal-title":"EJNMMI Phys"},{"issue":"3","key":"10.1016\/j.ctro.2025.101040_b0025","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00259-002-1076-y","article-title":"Tumour dosimetry and response in patients with metastatic differentiated thyroid cancer using recombinant human thyrotropin before radioiodine therapy","volume":"30","author":"de Keizer","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"12","key":"10.1016\/j.ctro.2025.101040_b0030","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1200\/JCO.2004.08.058","article-title":"Hematologic toxicity of high-dose iodine-131-metaiodobenzylguanidine therapy for advanced neuroblastoma","volume":"22","author":"DuBois","year":"2004","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.ctro.2025.101040_b0035","first-page":"399","article-title":"Dosimetric quantities in neuroendocrine tumors over treatment cycles with 177Lu-DOTATATE","volume":"63","author":"Roth","year":"2022","journal-title":"J Nucl Med off Publ Soc Nucl Med"},{"key":"10.1016\/j.ctro.2025.101040_b0040","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1479-5876-5-15","article-title":"Safety and efficacy of Y-90 microsphere treatment in patients with primary and metastatic liver cancer: the tumor selectivity of the treatment as a function of tumor to liver flow ratio","volume":"5","author":"Gulec","year":"2007","journal-title":"J Transl Med"},{"issue":"1\u20132","key":"10.1016\/j.ctro.2025.101040_b0045","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S1040-8428(01)00107-X","article-title":"Biodistribution and dosimetry results from a phase III prospectively randomized controlled trial of zevalin radioimmunotherapy for low-grade, follicular, or transformed B-cell Non-Hodgkin\u2019s Lymphoma","volume":"39","author":"Wiseman","year":"2001","journal-title":"Crit Rev Oncol Hematol"},{"issue":"7","key":"10.1016\/j.ctro.2025.101040_b0050","first-page":"1006","article-title":"177Lu-labeled prostate-specific membrane antigen radioligand therapy of metastatic castration-resistant prostate cancer: safety and efficacy","volume":"57","author":"Baum","year":"2016","journal-title":"J Nucl Med off Publ Soc Nucl Med"},{"issue":"9","key":"10.1016\/j.ctro.2025.101040_b0055","first-page":"1304","article-title":"A phase 1, open-label study of the biodistribution, pharmacokinetics, and dosimetry of 223Ra-dichloride in patients with hormone-refractory prostate cancer and skeletal metastases","volume":"56","author":"Chittenden","year":"2015","journal-title":"J Nucl Med off Publ Soc Nucl Med"},{"issue":"9","key":"10.1016\/j.ctro.2025.101040_b0060","first-page":"1467","article-title":"Dosimetry in peptide radionuclide receptor therapy: a review","volume":"47","author":"Cremonesi","year":"2006","journal-title":"J Nucl Med"},{"issue":"1","key":"10.1016\/j.ctro.2025.101040_b0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40658-024-00658-8","article-title":"A Review of 177Lu dosimetry workflows: how to reduce the imaging workloads?","volume":"11","author":"Vergnaud","year":"2024","journal-title":"EJNMMI Phys"},{"issue":"11","key":"10.1016\/j.ctro.2025.101040_b0070","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.2967\/jnumed.108.053173","article-title":"20: the effect of model assumptions on kidney dosimetry and response\u2014implications for radionuclide therapy","volume":"49","author":"Wessels","year":"2008","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ctro.2025.101040_b0075","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3389\/fmed.2015.00012","article-title":"Introduction to radiobiology of targeted radionuclide therapy","volume":"2","author":"Pouget","year":"2015","journal-title":"Front Med"},{"issue":"11","key":"10.1016\/j.ctro.2025.101040_b0080","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1007\/s00259-021-05345-9","article-title":"EANM position paper on the role of radiobiology in nuclear medicine","volume":"48","author":"Aerts","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"Supplement 3","key":"10.1016\/j.ctro.2025.101040_b0085","doi-asserted-by":"crossref","DOI":"10.2967\/jnumed.121.262754","article-title":"Dosimetry for radiopharmaceutical therapy: the European perspective","volume":"62","author":"Lassmann","year":"2021","journal-title":"J Nucl Med"},{"issue":"1","key":"10.1016\/j.ctro.2025.101040_b0090","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s40658-020-0282-7","article-title":"In collaboration with the EANM dosimetry committee. EANM dosimetry committee series on standard operational procedures for internal dosimetry for 131I mIBG treatment of neuroendocrine tumours","volume":"7","author":"Gear","year":"2020","journal-title":"EJNMMI Phys"},{"key":"10.1016\/j.ctro.2025.101040_b0095","unstructured":"IAEA. Cytogenetic Dosimetry: Applications in Preparedness for and Response to Radiation Emergencies. 2011."},{"issue":"10","key":"10.1016\/j.ctro.2025.101040_b0100","doi-asserted-by":"crossref","first-page":"5858","DOI":"10.1074\/jbc.273.10.5858","article-title":"DNA double-stranded breaks induce histone H2AX Phosphorylation on serine 139","volume":"273","author":"Rogakou","year":"1998","journal-title":"J Biol Chem"},{"issue":"20","key":"10.1016\/j.ctro.2025.101040_b0105","first-page":"5149","article-title":"Histones in functional diversification","volume":"272","author":"Pusarla","year":"2005","journal-title":"Core Histone Variants FEBS J"},{"issue":"9","key":"10.1016\/j.ctro.2025.101040_b0110","doi-asserted-by":"crossref","first-page":"5057","DOI":"10.1073\/pnas.0830918100","article-title":"Evidence for a lack of DNA double-strand break repair in human cells exposed to very low x-ray doses","volume":"100","author":"Rothkamm","year":"2003","journal-title":"PNAS"},{"issue":"12","key":"10.1016\/j.ctro.2025.101040_b0115","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/nrc2523","article-title":"GammaH2AX and cancer","volume":"8","author":"Bonner","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ctro.2025.101040_b0120","doi-asserted-by":"crossref","DOI":"10.1007\/s00411-017-0696-3","article-title":"Cytogenetic biodosimetry and dose-rate effect after radioiodine therapy for thyroid cancer","volume":"56","author":"Khvostunov","year":"2017","journal-title":"Radiat Environ Biophys"},{"issue":"4","key":"10.1016\/j.ctro.2025.101040_b0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0123174","article-title":"Calibration of the \u03b3-H2AX DNA double strand break focus assay for internal radiation exposure of blood lymphocytes","volume":"10","author":"Eberlein","year":"2015","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ctro.2025.101040_b0130","doi-asserted-by":"crossref","first-page":"477","DOI":"10.2967\/jnumed.108.056036","article-title":"MIRD Pamphlet No. 21: a generalized schema for radiopharmaceutical dosimetry\u2014standardization of nomenclature","volume":"50","author":"Bolch","year":"2009","journal-title":"J Nucl Med"},{"issue":"2","key":"10.1016\/j.ctro.2025.101040_b0135","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/01.HP.0000346305.84577.b4","article-title":"Dose estimation software for radiation biodosimetry","volume":"98","author":"Ainsbury","year":"2010","journal-title":"Health Phys"},{"issue":"6","key":"10.1016\/j.ctro.2025.101040_b0140","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.3390\/ijms25063355","article-title":"Senescence-associated heterochromatin foci suppress \u03b3-H2AX focus formation induced by radiation exposure","volume":"25","author":"Oizumi","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.ctro.2025.101040_b0145","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00411-015-0628-z","article-title":"In vitro RABiT measurement of dose rate effects on radiation induction of micronuclei in human peripheral blood lymphocytes","volume":"55","author":"Bertucci","year":"2016","journal-title":"Radiat Environ Biophys"},{"key":"10.1016\/j.ctro.2025.101040_b0150","doi-asserted-by":"crossref","first-page":"2","DOI":"10.4103\/genint.genint_1_19","article-title":"Development of dose-response calibration curve for dicentric chromosome induced by X-rays","volume":"10","author":"Lusiyanti","year":"2019","journal-title":"Genome Integr"},{"issue":"1","key":"10.1016\/j.ctro.2025.101040_b0155","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/oxfordjournals.rpd.a006333","article-title":"Dose rate effect on micronucleis induction in cytokinesis blocked human peripheral blood lymphocytes","volume":"106","author":"Bhat","year":"2003","journal-title":"Radiat Prot Dosim"},{"issue":"2","key":"10.1016\/j.ctro.2025.101040_b0160","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00411-006-0045-4","article-title":"The effect of the \u03b2-emitting yttrium-90 citrate on the dose\u2013response of dicentric chromosomes in human lymphocytes: a basis for biological dosimetry after radiosynoviorthesis","volume":"45","author":"Schmid","year":"2006","journal-title":"Radiat Environ Biophys"},{"issue":"5","key":"10.1016\/j.ctro.2025.101040_b0165","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.molcel.2005.10.003","article-title":"\u03b3-H2AX dephosphorylation by protein phosphatase 2A facilitates DNA double-strand break repair","volume":"20","author":"Chowdhury","year":"2005","journal-title":"Mol Cell"},{"issue":"11","key":"10.1016\/j.ctro.2025.101040_b0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0079541","article-title":"Use of the \u03b3-H2AX assay to investigate DNA repair dynamics following multiple radiation exposures","volume":"8","author":"Mariotti","year":"2013","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.ctro.2025.101040_b0175","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1007\/s00259-021-05605-8","article-title":"DNA damage and repair in peripheral blood mononuclear cells after internal Ex vivo irradiation of patient blood with 131I","volume":"49","author":"Schumann","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"10.1016\/j.ctro.2025.101040_b0180","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1038\/s41598-020-59163-4","article-title":"Chronic irradiation of human cells reduces histone levels and deregulates gene expression","volume":"10","author":"Lowe","year":"2020","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.ctro.2025.101040_b0185","first-page":"167","article-title":"GSK3\u03b2 activity is essential for senescence-associated heterochromatin foci (SAHF) formation induced by HMGA2 in WI38 cells","volume":"9","author":"Shi","year":"2017","journal-title":"Am J Transl Res"},{"issue":"1","key":"10.1016\/j.ctro.2025.101040_b0190","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41392-023-01451-2","article-title":"Immunosenescence: molecular mechanisms and diseases","volume":"8","author":"Liu","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.ctro.2025.101040_b0195","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.988713","article-title":"Radiation therapy induces immunosenescence mediated by p90RSK","volume":"9","author":"Imanishi","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.ctro.2025.101040_b0200","doi-asserted-by":"crossref","first-page":"11938","DOI":"10.1038\/ncomms11938","article-title":"Chromatin accessibility maps of chronic lymphocytic leukaemia identify subtype-specific epigenome signatures and transcription regulatory networks","volume":"7","author":"Rendeiro","year":"2016","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.ctro.2025.101040_b0205","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/acel.12047","article-title":"Genomes of replicatively senescent cells undergo global epigenetic changes leading to gene silencing and activation of transposable elements","volume":"12","author":"De Cecco","year":"2013","journal-title":"Aging Cell"},{"key":"10.1016\/j.ctro.2025.101040_b0210","doi-asserted-by":"crossref","unstructured":"Moskowitz, D. M.; Zhang, D. W.; Hu, B.; Le Saux, S.; Yanes, R. E.; Ye, Z.; Buenrostro, J. D.; Weyand, C. M.; Greenleaf, W. J.; Goronzy, J. J. Epigenomics of Human CD8 T Cell Differentiation and Aging. Sci Immunol 2017, 2 (8), eaag0192. https:\/\/doi.org\/10.1126\/sciimmunol.aag0192.","DOI":"10.1126\/sciimmunol.aag0192"},{"issue":"6","key":"10.1016\/j.ctro.2025.101040_b0215","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1083\/jcb.200604005","article-title":"Loss of linker histone H1 in cellular senescence","volume":"175","author":"Funayama","year":"2006","journal-title":"J Cell Biol"},{"issue":"6316","key":"10.1016\/j.ctro.2025.101040_b0220","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1126\/science.aae0491","article-title":"The epigenetic landscape of T cell exhaustion","volume":"354","author":"Sen","year":"2016","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.ctro.2025.101040_b0225","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.cell.2017.06.007","article-title":"Novo epigenetic programs inhibit PD-1 blockade-mediated T cell rejuvenation","volume":"170","author":"Ghoneim","year":"2017","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.ctro.2025.101040_b0230","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/j.1474-9726.2012.00819.x","article-title":"Upregulation of miR-24 is associated with a decreased DNA damage response upon etoposide treatment in highly differentiated CD8(+) T cells sensitizing them to apoptotic cell death","volume":"11","author":"Brunner","year":"2012","journal-title":"Aging Cell"},{"issue":"2","key":"10.1016\/j.ctro.2025.101040_b0235","first-page":"173","article-title":"DNA damage in peripheral blood lymphocytes of thyroid cancer patients after radioiodine therapy","volume":"57","author":"Eberlein","year":"2016","journal-title":"J Nucl Med off Publ Soc Nucl Med"},{"issue":"10","key":"10.1016\/j.ctro.2025.101040_b0240","doi-asserted-by":"crossref","first-page":"5493","DOI":"10.3390\/ijms25105493","article-title":"Modelling the in vivo and Ex Vivo DNA damage response after internal irradiation of blood from patients with thyroid cancer","volume":"25","author":"Schumann","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"8","key":"10.1016\/j.ctro.2025.101040_b0245","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.2967\/jnumed.109.071357","article-title":"In vivo formation of \u03b3-H2AX and 53BP1 DNA repair foci in blood cells after radioiodine therapy of differentiated thyroid cancer","volume":"51","author":"Lassmann","year":"2010","journal-title":"J Nucl Med"}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630825001326?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630825001326?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T18:16:02Z","timestamp":1772907362000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405630825001326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":49,"alternative-id":["S2405630825001326"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2025.101040","relation":{},"ISSN":["2405-6308"],"issn-type":[{"value":"2405-6308","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Continuous \u03b2\u2212 particle exposure: A study of DNA damage in ex vivo peripheral blood mononuclear cells irradiation with Radioiodine","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2025.101040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}],"article-number":"101040"}}